Latest Executive Appointment News

Fleetwood Limited has announced the immediate departure of CEO Bruce Nicholson, with Chair John Klepec stepping in as interim CEO while a search for a permanent replacement begins.

Orcoda Limited announces a pivotal leadership transition with Patrick Bodegraven stepping in as Managing Director, while long-serving Geoff Jamieson shifts to a part-time CFO role to support continuity.

Pacific Current Group has confirmed key leadership appointments with Michael Clarke named Managing Director and CEO, and Ron Patel taking on the role of Acting CFO, signaling continuity and financial stewardship.

dorsaVi Limited has acquired a cutting-edge neuromorphic processing-in-memory technology portfolio, positioning itself at the forefront of next-generation wearable and robotics intelligence. This strategic move, coupled with leadership changes, signals a new era for the company’s adaptive biosensor and robotics platforms.

Golden State Mining has appointed Keith Middleton as Managing Director and CEO, bringing over two decades of mining sector expertise and a strategic vision for growth. His leadership comes with a significant share-based incentive, signaling a new chapter for the exploration company.

Lodestar Minerals reports promising gold drilling results at Ned’s Creek, advances exploration in Chile, and announces a strategic acquisition of a US rare earth project.

Gateway Mining has completed its acquisition of the Yandal Gold Project, revealing promising high-grade gold results and securing $22.5 million to fuel extensive exploration and drilling programs.

Ovanti Limited has made significant strides in its U.S. buy now, pay later (BNPL) expansion, securing a major partnership with Shift4 Payments and raising $8 million to fuel growth.

Thunderbird Resources has executed a binding agreement to acquire 100% of the Springfield Gold Deposit in NSW, an advanced project with significant high-grade gold mineralisation. The company also raised $2.2 million to fund exploration and appointed new senior executives to drive growth.

RocketBoots Limited has secured new trial contracts worth $208,000 with major retail banks in Australia and Mexico, while expanding its international sales pipeline and appointing a seasoned CFO/COO to support growth.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Percheron Therapeutics reports encouraging phase I clinical results for HMBD-002, confirming safety and early efficacy signals, while gearing up for a multi-arm phase II trial in 2026.